With the exception of the minority of patients with acute myelocytic leukemia who are considered potentially cured by chemotherapy, hematopoietic cell transplantation (HCT) has traditionally been the ...
A Yale study published on the cover of the journal Blood explains basic scientific discoveries that could lead to innovative therapies for acute myeloid leukemia, and specifically a rare and ...
Peter Mac researchers have discovered a powerful new drug combination that could offer hope to children and adults with certain subtypes of acute myeloid leukemia (AML). The treatment works by using a ...
Hosted on MSN
Aza–ven combination outperforms standard care in AML patients eligible for intensive chemotherapy
In a new trial, patients newly diagnosed with acute myeloid leukemia (AML) fared significantly better with a combined regimen of azacitidine and venetoclax compared with conventional induction ...
The CytoCell KMT2A Breakapart FISH Probe Kit PDx is approved as a companion diagnostic for revumenib in KMT2A translocated acute leukemia. Revumenib showed a 21.2% complete remission rate in ...
Incidence of acute leukemia in pregnancy is extremely low, symptoms overlap with gestation, and delayed diagnosis amplifies the need for coordinated hematology–maternal-fetal management. A 23-patient ...
Researchers at Dana-Farber Cancer Institute have developed a groundbreaking diagnostic tool that could transform the way acute leukemia is identified and treated. The tool, called MARLIN (Methylation- ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results